or Try an Advanced Search...

    Psychiatric Diagnosis Stocks List

    Symbol Grade Name % Change
    LFST C LifeStance Health Group, Inc. 0.73
    LLY D Eli Lilly and Company 0.18
    SAVA D Cassava Sciences, Inc. 0.45
    ITCI D Intra-Cellular Therapies Inc. 0.89
    RVPH D Reviva Pharmaceuticals Holdings, Inc. 2.46
    ACIU D AC Immune SA -0.29
    IGC F India Globalization Capital Inc. 2.35
    ANVS F Annovis Bio, Inc. 4.86
    IKT F Inhibikase Therapeutics, Inc. -0.79
    ALZN F Alzamend Neuro, Inc. 1.84
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Devices
    Related Stock Lists: Alzheimer's Disease Parkinson's Disease Psychiatry Bipolar Disorder Dementia Mental Health Neurodegeneration Neuroscience Biology Disorders Major Depressive Disorder Schizophrenia Abnormal Psychology Aging Associated Diseases Amyloid Clinical Medicine Cognitive Disorders Cognitive Impairment Depression Depressive Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Psychiatric Diagnosis stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 24.89
    OZEM F Roundhill GLP-1 & Weight Loss ETF 19.98
    MEDX D Horizon Kinetics Medical ETF 16.63
    THNR F Amplify Weight Loss Drug & Treatment ETF 14.78
    PPH D Market Vectors Pharmaceutical ETF 12.76
    View all Psychiatric Diagnosis ETFs...
    Compare ETFs
    Compare IHE to THNR Compare MEDX to THNR Compare OZEM to PPH

        Psychiatric Diagnosis Stocks Recent News

        Date Stock Title
        Oct 4 LLY Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know
        Oct 4 LLY Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
        Oct 4 LLY Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
        Oct 4 LLY What end of Eli Lilly's weight-loss drug shortage means for the competition
        Oct 4 LLY Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list
        Oct 4 LLY England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
        Oct 4 LLY AbbVie Cuts 2024 Earnings Guidance to Include Acquisition Costs
        Oct 4 LLY NHS proposes phased launch for Eli Lilly’s Mounjaro
        Oct 4 LLY As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
        Oct 4 LLY Top T. Rowe Price Fund Manager Shares Her Secrets
        Oct 4 LLY Texas sues major PBMs, pharma companies over high insulin prices
        Oct 4 LLY Ozempic for all, Zepbound is back, and the top CEO pay: Pharma news roundup
        Oct 3 LLY Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
        Oct 3 LLY Top Research Reports for Exxon Mobil, Mastercard and Procter & Gamble
        Oct 3 LLY Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
        Oct 3 LLY For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
        Oct 3 LLY Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant
        Oct 3 LLY Update: Eli Lilly, CVS Among Companies Facing Lawsuit Over Inflated Insulin Prices
        Oct 3 LLY Sector Update: Health Care Stocks Softer Thursday Afternoon
        Oct 3 LLY Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Devices
        Related Stock Lists: Alzheimer's Disease Parkinson's Disease Psychiatry Bipolar Disorder Dementia Mental Health Neurodegeneration Neuroscience Biology Disorders Major Depressive Disorder Schizophrenia Abnormal Psychology Aging Associated Diseases Amyloid Clinical Medicine Cognitive Disorders Cognitive Impairment Depression Depressive Disorder
        Psychiatric Diagnosis

        Psychiatric diagnosis is the process of determining which mental disorder or disorder a person has, based on a thorough evaluation of the person's symptoms and history. This process typically involves a mental health professional, such as a psychiatrist, psychologist, or clinical social worker, interviewing the person and gathering information from family members, friends, and other sources. The diagnosis is then used to develop a treatment plan that is tailored to the individual's needs.

        Browse All Tags